IP Library Granted Patent US 9,121,054
Granted Patent B2
US 9,121,054 · App. 12/962,202 · Granted Sep 1, 2015

Detection of nucleic acid amplification products in the presence of an internal control sequence on an immunochromatographic strip

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,121,054
App. No.
12/962,202
Granted
Sep 1, 2015
Kind
B2
Abstract

Compositions and methods useful in nucleic acid assays are provided. The invention permits detection of test and control nucleic acids. Test nucleic acids can be immobilized at multiple locations, such that amplification of either a test nucleic acid or a control nucleic acid provides a captured nucleic acid in a control capture zone.

Claims (12)

1. A nucleic acid assay method, the method comprising:

performing a nucleic acid amplification reaction to amplify a control nucleic acid and a test nucleic acid, wherein the performing the nucleic acid reaction generates a reaction product composition which comprises a test product comprising a first label, a test product comprising a second label, and/or a control product comprising the second label;

contacting the reaction product composition with a lateral flow strip after the performing the nucleic acid reaction, wherein the lateral flow strip comprises a control capture zone and a test capture zone;

wherein the control product, if present, is captured in the control capture zone; the test product comprising the first label, if present, is captured in the test capture zone, and the test product comprising the second label, if present, is captured in the control capture zone; and

wherein successful amplification of either the control nucleic acid or the test nucleic acid provides a captured nucleic acid in the control capture zone.

2. The method of claim 1 , further comprising detecting the captured control product, the captured test product comprising the first label, and/or the captured test product comprising the second label.

3. The method of claim 1 , wherein the nucleic acid amplification reaction is a helicase dependent amplification (HDA) reaction.

4. The method of claim 1 , wherein a first antibody is immobilized to the test capture zone and a second antibody is immobilized to the control capture zone.

5. The method of claim 4 , wherein the first antibody specifically binds to the test product comprising the first label and the second antibody specifically binds to the control product comprising the second label and the test product comprising the second label.

6. The method of claim 1 , wherein the test product comprising the first label is captured in the control capture zone.

7. The method of claim 6 , wherein a first antibody is immobilized to the test capture and to the control capture zone and a second antibody is immobilized to the control capture zone.

8. The method of claim 7 , wherein the first antibody specifically binds to the test product comprising the first label and the second antibody specifically binds to the control product comprising the second label and the test product comprising the second label.

Assignments (7)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: BIOHELIX CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0661 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2012
From: KONG, HUIMIN; TONG, YANHONG; TANG, WEN
To: BIOHELIX CORPORATION
Reel/Frame 029312/0905 →